TGFB1 and peripheral arterial disease: Plasma levels of TGFβ1, a cytokine for which both pro- and anti-angiogenic functions have been reported, also did not differ in PAD patients, in contrast to a previous study, in which total, not active TGFβ1, levels were measured in patients with PAD [53].